GBA's "2021 Stock Phantasma"

Discussion in 'Stocks' started by stonedinvestor, Jan 1, 2021.

  1. A gentleman’s guide to peacocking

    Shake your tail feathers, gentlemen...

    [​IMG]



    Which iconic men ate gummys?
    There is little as daunting as dating – that much is clear. And, of all the steps and stages of a relationship, the initial meeting is surely the most daunting – and difficult – of them all.

    So how can you make the best possible first impression? How can you cut through the competition, stand out from the crowd and attract the woman of your dreams? The answer: Peacocking.

    It may sound like some kind of exotic bird poaching, but peacocking is thoroughly footed in fashion. A sartorial system – devised to ensure you attract the most attention as possible in a social setting – this practice follows the same principles used by a male peacock’s tail plumage.

    And it’s hardly new. Peacocking has been around for years, but you’ve probably just dismissed the men you’ve seen in bars and clubs, dressed ostentatiously in bright clothing and bearing flamboyant accessories, as lunatics.

    Not so. These proud peacocks are doing it right, gentleman – and probably getting considerably more action that you as a result.

    So how can you dive into the theatrical and exuberant world of peacocking? As individuality is key, there are few rules to follow – but we’ve outlined some handy guidelines just in case…

    Know when to stop
     
    #2621     Mar 14, 2021
    vanzandt likes this.
  2. So Golf is Up and Hot--

    And so is gardening... last year was a break out year for flowers because of the Covid and many people have discovered the joy of what I have known for 16 years-- Gardening is the best! There is a show on Netflix I'm about to start about English gardening i love hat stuff. Thel atest numbers out of Miracle Grow are pretty astounding they are pumping that poison out non stop- I can't stand it- I am organic.. I am old school but gardening is in. Next week you will see my little seed stick start to move and then you will here more about the seed shortage....

    S&W Seed Company (SANW)
    NasdaqCM - NasdaqCM Real Time Price. Currency in USD
    Visitors trend2W10W9M
    $3.7500+0.0600 (+1.63%)
     
    #2622     Mar 14, 2021
  3. Also->
    Central Garden & Pet Company (CENT)
    $52.88+0.54 (+1.03%)
    At close: March 12 4:00PM EST
     
    #2623     Mar 14, 2021
  4. Golf + Luxury Shopping + time shares + gardening = $$$$$$$$
     
    #2624     Mar 14, 2021
  5. #2625     Mar 14, 2021
  6. vanzandt

    vanzandt

    Nobody cares about an individual's immunity.... they care about an individual spreading the stuff. Duh.


    Moving on....

    Regarding hotels,airlines etc on the "re-opening trade"....
    That's all well and good, but I see no reason for these stocks... take MGM for an example... to be trading at a decent premium to where they were pre-pandemic. It's at $39. (hey stoney, remember when I said it was a buy at $17 and you scoffed?) The damn thing lived around $30 +/- for years.
    What's changed? Nothing, even if the entire world does acquire herd immunity. Which it won't btw, anytime soon at least. Why this new huge premium?

    UAL is 35% higher than it was a year ago. Wtf?

    It doesn't take much brainpower here guys.
    The re-open trade, at least for certain stocks, is way the f overbought.
     
    Last edited: Mar 14, 2021
    #2626     Mar 14, 2021
  7. vanzandt

    vanzandt

    Ahhhhh..... if you want to be in this, SABR is the way to go.
    They've been around forever and I doubt they're sleeping.
    There's nothing proprietary here.
    It's mining data.
    And you're right, PLTR will have their hands in this pie too.
     
    #2627     Mar 14, 2021
  8. vanzandt

    vanzandt

    Stoney,
    More news out of the BLUE today.


    CAMBRIDGE, Mass. — (BUSINESS WIRE) — Mar. 15, 2021 — bluebird bio, Inc. (Nasdaq: BLUE) announced new data from the clinical development program for its investigational elivaldogene autotemcel (eli-cel, Lenti-D™) gene therapy in patients with cerebral adrenoleukodystrophy (CALD), including updated results from the pivotal Phase 2/3 Starbeam study (ALD-102) and the long-term follow-up study LTF-304, as well as safety outcomes from the Phase 3 ALD-104 study. Data were presented today in an oral presentation during the Presidential Symposium at the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT 2021), taking place virtually from March 14 - 17, 2021.

    http://archive.fast-edgar.com/20210315/AO22B22CZ22ZK2E2222I22Y2G8MN9Z224232/
     
    #2628     Mar 15, 2021
  9. GrowGeneration acquires Char Coir; accretive to revenue in 2021- strange pick up- alternative to rockwool?
    Mar. 15, 2021 8:14 AM ETGrowGeneration Corp. (GRWG)
    • GrowGeneration(NASDAQ:GRWG) trades 2.2% higher premarket after acquiring Char Coir, an RHP-certified growing medium made from the highest-grade coconut fiber available.
    • Char Coir's portfolio of products are 100% biodegradable and compostable and a sustainable alternative to rockwool.
    • Char Coir's line of coco products are expected to add $15M+ in revenue to GrowGen in 2021.
    • GrowGen reportedstrong Q4 prelimsin January.
     
    #2629     Mar 15, 2021
  10. Check-Cap shares soar on FDA IDE approval for pivotal C-Scan study
    Mar. 15, 2021 8:23 AM ETCheck-Cap Ltd. (CHEK)
    • Check-Cap(NASDAQ:CHEK)shares more than doubled during premarket tradingafter the company receivedapproval from the U.S. FDA for itsInvestigational Device Exemption (IDE) application, permitting it to begin a pivotal study of C-Scan in the U.S.
    • C-Scan is intended for candidates who are at average-risk for colorectal cancer (CRC) and who are poor candidates for colonoscopy or decline colonoscopy, or who had an incomplete optical colonoscopy.
    • The company said that it is actively in discussions with a number of clinical sites as part of its preparations to begin the pivotal study in late 2021.
    • It is also gearing up to initiate a study in Israel at more than 10 clinical sites to enroll up to 250 average risk patients.
     
    #2630     Mar 15, 2021